PTPN21

PTPN21 is a non-receptor cytosolic protein tyrosine phosphatase built from an N-terminal FERM domain and a C-terminal PTP domain, an architecture that places it at the intersection of cytoskeletal organization, intracellular transport, and receptor tyrosine kinase signaling (PMID:7838537). Its phosphatase activity is intrinsically weak and held in check by an intramolecular autoinhibitory interaction in which the FERM domain directly contacts and sterically occludes the PTP active site; disrupting this interface enhances ERK activation (PMID:38416831). The FERM domain is the principal targeting and effector module: it binds the tail of the kinesin-3 motor KIF1C to relieve its motor-domain autoinhibition, increasing microtubule landing rate and activating processive plus-end transport of dense core vesicles and integrins (PMID:31217419), and it localizes PTPN21 to the plasma membrane and adhesion plaques where the enzyme assembles with actin, Src, and FAK to drive EGF-induced FAK autophosphorylation, ERK signaling, and cell migration in a manner requiring both catalytic activity and the FERM domain (PMID:18223254, PMID:25062045). PTPN21 acts on defined substrates to control distinct outputs: it dephosphorylates Septin1 at Tyr246 to support cytoskeletal stiffness and retention of hematopoietic stem cells in the bone marrow niche (PMID:30880025), dephosphorylates ErbB4 to potentiate downstream Elk-1/NRG3 signaling in cortical neurons (PMID:25681686), and dephosphorylates IKKβ at Ser177/181 to stabilize IκBα and suppress NF-κB-driven ICAM-1 expression (PMID:29065968). The FERM-dependent migratory function is conserved, with the Drosophila ortholog Pez acting with Src42A and the Draper receptor downstream of wound-induced H2O2 to drive macrophage recruitment, a role retained in zebrafish leukocyte recruitment (PMID:33296680). The HPV18 E7 oncoprotein binds the PTP domain at the same interface used by the FERM domain, displacing autoinhibition and engaging PTPN21 to promote cell migration and invasion (PMID:33431714, PMID:38416831).

1. 1995 Medium

   Established the founding domain architecture, defining PTPN21 as a cytosolic non-receptor PTP carrying an N-terminal FERM-like (band 4.1/ezrin homology) region.

   Evidence PCR cloning, cDNA sequencing, and Northern blotting of regenerating mouse liver

   PMID:7838537

   Open questions at the time

   • No functional role assigned to either domain
   • No substrate identified
   • No subcellular localization determined
2. 2008 High

   Showed PTPN21 is not a free-standing enzyme but a scaffolded one, assembling with actin, Src, and FAK at adhesion plaques where both its catalytic activity and FERM domain are required for EGF-driven FAK phosphorylation and migration.

   Evidence Reciprocal Co-IP, shRNA silencing, catalytic-dead (C1108S) and FERM-deleted mutant dissection, migration assays

   PMID:18223254

   Open questions at the time

   • Direct substrate within the Src-FAK module not pinned down
   • Single lab
   • Mechanism of FERM-mediated complex assembly not resolved structurally
3. 2010 Medium

   Linked PTPN21 to receptor trafficking by placing it on EGFR-containing endosomes via the kinesin KIF16B, connecting its localization to EGFR stability and ERK output.

   Evidence Co-IP with KIF16B, siRNA silencing, receptor degradation and ERK readouts

   PMID:20923765

   Open questions at the time

   • Single Co-IP-based interaction without structural mapping
   • Phosphatase substrate on the endosome not identified
   • Single study
4. 2014 Medium

   Refined the membrane localization mechanism, showing the FERM domain targets PTPN21 to pre-existing EGFR signaling complexes at the plasma membrane to propagate peripheral EGFR phosphorylation.

   Evidence Live-cell imaging, FRAP, FERM-domain deletion/mutation, EGFR phosphorylation assays, siRNA knockdown

   PMID:25062045

   Open questions at the time

   • Direct molecular contacts of FERM with the membrane/EGFR complex not defined
   • Single lab
   • Catalytic contribution at the membrane not separated from scaffolding
5. 2015 Medium

   Identified ErbB4 as a direct substrate and connected dephosphorylation to a transcriptional program (Elk-1/NRG3) governing cortical neuronal survival and neurite outgrowth.

   Evidence Receptor tracking, IP, phosphatase-dead and kinase-dead mutants, Elk-1 reporter, neuron survival/neurite assays

   PMID:25681686

   Open questions at the time

   • Phospho-site on ErbB4 not mapped
   • Single lab
   • In vivo relevance in brain not tested genetically
6. 2017 Medium

   Extended substrate repertoire into inflammatory signaling by showing PTPN21 dephosphorylates IKKβ at Ser177/181 to suppress NF-κB and ICAM-1.

   Evidence Overexpression and C1108S mutant, Western blot for p-IKKβ/IκBα/NF-κB targets, ICAM-1 assays in keratinocytes

   PMID:29065968

   Open questions at the time

   • Note: IKKβ substrate sites are Ser, atypical for a tyrosine phosphatase, unresolved here
   • Single lab and study
   • Direct in vitro dephosphorylation not shown
7. 2019 High

   Established a high-confidence physiological substrate-phenotype axis: Ptpn21 dephosphorylates Septin1 Tyr246 to maintain HSC stiffness, quiescence, and niche retention.

   Evidence Ptpn21 knockout mice, atomic force microscopy, phospho-specific Septin1 Tyr246 detection, egress and reconstitution assays

   PMID:30880025

   Open questions at the time

   • Whether Septin1 is dephosphorylated directly versus indirectly not fully resolved
   • Role of FERM/autoinhibition in this context untested
8. 2019 High

   Defined a non-catalytic transport-activating function: the FERM domain binds KIF1C to relieve motor autoinhibition and switch on processive cargo transport.

   Evidence In vitro reconstitution with purified KIF1C and PTPN21 FERM, landing-rate assays, integrin trafficking rescue, neuronal vesicle transport

   PMID:31217419

   Open questions at the time

   • Whether full-length PTPN21 (with autoinhibition) engages KIF1C identically not addressed
   • Coupling of transport activation to phosphatase activity unknown
9. 2020 High

   Demonstrated evolutionary conservation of a FERM-dependent migratory role, placing PTPN21/Pez downstream of wound H2O2 with Src and the Draper receptor to drive immune cell recruitment.

   Evidence Drosophila genetics/epistasis, proteomics, live imaging, CRISPR crispant zebrafish

   PMID:33296680

   Open questions at the time

   • Catalytic substrate in this pathway not identified
   • Human leukocyte relevance inferred from zebrafish
10. 2024 High

    Provided the structural basis for regulation, showing FERM-PTP intramolecular contact autoinhibits the weak phosphatase and that HPV18 E7 binds the PTP at the FERM interface to displace autoinhibition.

    Evidence X-ray crystallography of FERM, PTP, and complex; phosphatase assays; interface mutagenesis; ERK activation; Kd determination of E7 binding

    PMID:33431714 PMID:38416831

    Open questions at the time

    • How physiological FERM ligands (KIF1C, membrane) relieve autoinhibition not structurally shown
    • Conformational dynamics in cells not visualized
11. 2024 Low

    Associated PTPN21 with leukemia cell proliferation and chemoresistance through Src/MAPK and GADD45A/JNK pathways.

    Evidence Lentiviral overexpression/knockdown in ALL cells, pathway inhibitors, GADD45A rescue, proliferation/apoptosis assays

    PMID:38785187 PMID:40305474

    Open questions at the time

    • Pathway placement by inhibitor/rescue only, no direct substrate identified
    • Single lab per study
    • Causal direction of GADD45A/JNK regulation not mechanistically resolved

• How physiological FERM-domain ligands relieve intramolecular autoinhibition to switch on phosphatase activity at specific subcellular sites, and how transport-activating versus catalytic functions are coordinated, remain unresolved.
• No structure of full-length PTPN21 bound to a physiological FERM ligand
• Unclear whether catalytic and KIF1C-activating activities operate simultaneously
• Substrate selection rules across tissues not defined